News

TriCalm® Launches Two New Products Offering Fast, Steroid-Free Itch Relief
San Diego, CA—Cosmederm Bioscience, Inc. today announced the expansion of its itch-relief product line, TriCalm®, with the new TriCalm Clinical Repair Cream and TriCalm Extra Strength Spray. Following the success of the company’s initial product, TriCalm Hydrogel, these two new offerings strategically expand the brand’s line of steroid-free, anti-itch products to further benefit sufferers of itch. Clinical Repair Cream is ideal for those suffering from dry, itchy skin, while Extra Strength Spray is formulated for use on contagious or hard-to-reach areas, such as rashes from poison oak or ivy. The... Read more...
Introducing Itch Free Zone, the Destination Where Itch Sufferers Become Informed and Empowered
San Diego, CA – Cosmederm Bioscience, Inc. today announced ItchFreeZone.com, a new resource for all things itch. ItchFreeZone is dedicated to addressing this often-debilitating condition and features insights from top itch experts, doctors and supporters. More than 300 million people suffer from acute itch every year and more than 110 million suffer from chronic itch conditions such as atopic dermatitis, psoriasis, seborrheic dermatitis and diabetic itch. Yet, there is not a single online destination devoted to educating and empowering itch sufferers. ItchFreeZone aims to fill this significant unmet need. The... Read more...
New Clinical Research Finds TriCalm® Hydrogel’s Itch Relief Significantly Superior to Leading OTC Treatments
San Diego, CA – A study conducted to assess the antipruritic effect of over-the-counter (OTC) steroid-free topical hydrogel formulation, TriCalm®, in reducing itch intensity and duration, has been published in Clinical, Cosmetic, and Investigational Dermatology. The study, which utilized a cowhage itch model, concluded that TriCalm hydrogel is significantly superior to diphenhydramine 2% and hydrocortisone 1%. “The results of this study are a testament to TriCalm’s value as the most effective over-the-counter itch relief treatment,” said Sean Edwards, President and CEO, Cosmederm Bioscience, Inc. “They validate our claim that TriCalm... Read more...
Cosmederm Bioscience Names Kristine Foss as New VP of Regulatory and Quality
San Diego, CA—Cosmederm Bioscience has appointed Kristine Foss as the Vice President of Regulatory and Quality. Foss will be responsible for leading and managing the Cosmederm team in strategic development and execution of all regulatory compliance plans and processes. She will also provide counsel to the company’s development team regarding interpretation of FDA and other regulatory authorities’ requirements. “I’m impressed by the work Cosmederm Bioscience has been doing in the areas of drug development, aesthetic medicine and dermatology. I look forward to helping the company achieve even more in 2015”... Read more...
National Eczema Association Adds TriCalm to List of ‘Accepted’ Products
Steroid-Free Anti-Itch TriCalm Receives NEA Seal of Acceptance San Diego, CA—Everyone knows how frustrating the itch of an insect bite can be, but imagine if that itch lasted for months or longer? Chronic itchy skin affects millions of Americans who suffer from eczema, a term for a group of medical conditions that cause the skin to become inflamed or irritated. Today, the National Eczema Association (NEA) granted TriCalm® Anti-Itch Hydrogel its Seal of Acceptance, recognizing it as a product appropriate for the care of itch related to eczema or sensitive... Read more...
Cosmederm Bioscience Announces $50M Investment by UK Investment Group
San Diego, CA—Cosmederm Bioscience has announced that UK-based Woodford Investment Management is investing $50 million into Cosmederm Bioscience. “We are thrilled about this investment by Woodford Investment Management. It is a testament to our technology platform and the market opportunities that exist in the areas of dermatology and pain management. The capital will allow us to accelerate the growth of our Refinity aesthetic brand, our TriCalm® OTC dermatology brand as well as our drug development programs,” said Cosmederm Bioscience CEO, Sean Edwards. About Cosmederm Bioscience Cosmederm Bioscience is a specialty... Read more...